In their research, AIMP1 was reported to regulate histone H3 acetylation via interacting with ANP32A and promoted the proliferation of MM cells by the MAPK signaling pathway, cooperatively enhancing osteoclastogenesis with the modulation of RANKL to activate NFATc1 [116]. Here, AIMP1 is linked to Miyoshi myopathy.